导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 44.89% | 55/1050 |
| 近一周 | 4.71% | 4/1104 |
| 近一月 | -4.42% | 548/1102 |
| 近一季 | -17.12% | 903/1092 |
| 近半年 | 20.09% | 139/1070 |
| 近一年 | 44.06% | 96/1018 |
| 近两年 | 130.31% | 122/926 |
| 近三年 | 63.70% | 183/834 |
| 成立以来 | 147.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
15.27% 16/1070 |
75.49% 128/1101 |
- - |
- - |
| 2025 | 28.19% 504/1065 |
7.23% 269/1014 |
-0.27% 712/1038 |
21.14% 574/1050 |
-1.06% 500/1065 |
| 2024 | -11.19% 784/1011 |
-12.53% 838/960 |
-10.56% 882/983 |
13.62% 334/991 |
-0.08% 323/1011 |
| 2023 | -15.09% 525/952 |
-1.05% 669/880 |
-0.73% 224/895 |
-14.21% 753/915 |
0.77% 100/952 |
| 2022 | -20.65% 349/867 |
-22.05% 639/773 |
7.26% 389/806 |
-6.02% 81/845 |
0.98% 384/867 |
| 2021 | 26.75% 94/740 |
-9.79% 486/580 |
26.13% 70/659 |
-2.84% 284/704 |
14.65% 27/740 |
| 2020 | 114.66% 13/554 |
-5.99% 315/419 |
37.57% 42/466 |
26.91% 14/517 |
30.79% 38/554 |
| 2019 | 40.80% 213/410 |
14.47% 1014/1146 |
-8.11% 909/1228 |
9.80% 114/390 |
21.91% 9/410 |
| 2018 | -24.10% 131/349 |
- - |
-11.53% 579/990 |
-4.01% 419/1000 |
-2.55% 29/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏节能环保股票A VS. 东吴新产业精选股票A(580008) |